Our findings suggest that GSK‐3β activation index is a potential indicator for recurrent inflammation of CRSsNP, and the insufficient inhibition of GSK‐3β by phosphorylation may play a pivotal role in the pathogenesis of CRSsNP. This evidence concerns the gene GSK3B and chronic rhinosinusitis without nasal polyps.